Summary of Study ST002133

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001351. The data can be accessed directly via it's Project DOI: 10.21228/M83699 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002133
Study TitleMetabolite variation in the blood serum of HIV carrier patients treated with effervescent glutamine
Study TypeLiquid NMR experiments
Study SummaryIt was demonstrated that effervescent glutamine supplementation in people living with HIV/AIDS increased the amount of CD4+ T lymphocytes. , decreased the serum levels of biomarkers of inflammation, and introduced health benefits. Herein, NMR spectroscopy was applied to evaluate if oral ingestion of glutamine (12.5 g) for 30 days can be measured through serum metabolite variations and if the reported benefits might correlate to small metabolites' changes in a chosen cohort of individuals. The HIV/AIDS group has been carefully selected and studied before and after the 30-days of supplementation with the glutamine, together with the matched non-HIV carrier patients' group. The group of HIV/AIDS individuals presented lower (p < 0.05) levels of choline, creatine, pyruvate, glutamate, lysine, and tyrosine when compared to the non-HIV carrier patients. On the other hand, serum concentrations of glucose, lipids, lactate, glutamine, phenylalanine, and threonine were higher (p < 0.05) in HIV/AIDS individuals. The variation in metabolites as a result of treatment with glutamine is consistent with the improvements observed in these patients and may lead us to suggest the introduction of the effervescent glutamine supplementation to antiretroviral therapies in people living with HIV/AIDS.
Institute
University of Campinas
DepartmentOrganic Chemistry
LaboratoryBiological Chemistry Lab
Last NameMARTINS
First NameLUCAS
AddressRua Josué de Castro, s/n - Cidade Universitária, Campinas - SP, 13083-970
Emaillgmartins1984@gmail.com
Phone+5519992947044
Submit Date2022-03-31
Num Groups3
Total Subjects24
Num Males10
Num Females14
Study CommentsCrossover study
Raw Data AvailableYes
Raw Data File Type(s)fid
Analysis Type DetailNMR
Release Date2022-04-27
Release Version1
LUCAS MARTINS LUCAS MARTINS
https://dx.doi.org/10.21228/M83699
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001351
Project DOI:doi: 10.21228/M83699
Project Title:Untargeted metabolomics of HIV carrier patients
Project Type:NMR-based metabolomics
Project Summary:Analysis of metabolite variation in HIV carrier patients blood serum in response to treatment with effervescent glutamine.
Institute:University of Campinas
Department:Organic Chemistry
Laboratory:Biological Chemistry Lab
Last Name:Martins
First Name:Lucas
Address:Cidade Universitário Zeferino Vaz, Campinas, SP, Brazil
Email:lgmartins1984@gmail.com
Phone:+5519992947044
Funding Source:FAPESP, INCT-Bio
  logo